Value
9.4/10data confidence 67%| Component | Sub-score |
|---|---|
| P/E | 8.5 |
| P/S | 9.6 |
| Fwd P/E | 9.4 |
| PEG | 10.0 |
- ▸Forward P/E: 9.2x
- ▸PEG: 0.39
- ▸Attractively valued
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Aegon is a cheaply valued insurer (forward P/E 8.7x) with a low-quality profile, declining revenue and negative cash conversion; at $8.18 the price is only 2.6% below the $8.39 analyst target, so little upside remains.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Pillar | Expectation | Trend |
|---|---|---|
Quality score is 3.6, below the 4.0 floor, with an earnings-quality red flag of -428% FCF/NI and no competitive moat. Quality breakdown | FCF/NI should turn positive and quality score rise above 4.0. | →Stable |
| CounterA Piotroski F-Score of 7/9 shows the underlying financials are healthy, and insurer cash flow is volatile from reserve and investment timing. | ||
Forward P/E of 8.7x and PEG of 0.39 make the value score 9.5, attractively valued against peers. Valuation breakdown | Forward P/E should remain below 10x as earnings are delivered over 12 months. | →Stable |
| CounterA low multiple on declining revenue and negative cash conversion may be a value trap rather than a bargain. | ||
The price of $8.18 is only 2.6% below the $8.39 analyst target, versus 5.0% downside to the stop, a reward-to-risk of 0.52. Analyst target | Analyst targets should be raised above $9 for meaningful upside to emerge. | →Stable |
| CounterAnother note shows analyst upside of 21% on unhaircut targets, so the gap may be larger than the conservative target suggests. | ||
Revenue is declining by 8% and the growth score is only 2.0. Growth breakdown | Revenue decline should narrow to better than -3% YoY. | →Stable |
| CounterInsurer revenue is distorted by investment and reserve movements, so the decline may not reflect the underlying business. | ||
A yield-trap warning flags the high dividend yield as unsafe, even though momentum is supported by rising on-balance volume and a price above the 200-day moving average. Catalyst breakdown | The dividend should be maintained and momentum score should stay at or above 5.4. | →Stable |
| CounterThe shares are supported by accumulation and the dividend has been maintained, so the warning may be overcautious. | ||
CounterA Piotroski F-Score of 7/9 shows the underlying financials are healthy, and insurer cash flow is volatile from reserve and investment timing.
CounterA low multiple on declining revenue and negative cash conversion may be a value trap rather than a bargain.
CounterAnother note shows analyst upside of 21% on unhaircut targets, so the gap may be larger than the conservative target suggests.
CounterInsurer revenue is distorted by investment and reserve movements, so the decline may not reflect the underlying business.
CounterThe shares are supported by accumulation and the dividend has been maintained, so the warning may be overcautious.
| Component | Sub-score |
|---|---|
| P/E | 8.5 |
| P/S | 9.6 |
| Fwd P/E | 9.4 |
| PEG | 10.0 |
| Component | Sub-score |
|---|---|
| ROE | 3.7 |
| ROA | 0.1 |
| Gross margin | 5.1 |
| Op margin | 2.3 |
| Net margin | 4.3 |
| Current ratio | 4.5 |
| FCF quality | 0.0 |
| Moat | 4.6 |
| Piotroski F | 7.8 |
| Component | Sub-score |
|---|---|
| Rev growth | 0.5 |
| EPS growth | 3.6 |
| Component | Sub-score |
|---|---|
| RSI | 5.0 |
| MACD | 6.9 |
| OBV | 10.0 |
| MA position | 7.0 |
| Volume | 3.4 |
| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 7.1 |
| erm sentiment | 4.0 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 3.5 |
| notable moves | 5.0 |
| Component | Sub-score |
|---|---|
| value rank | 6.1 |
| quality rank | 1.2 |
| growth rank | 1.7 |
| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 0.2 |
| 52w position | 8.3 |
| gap | 4.0 |
| Component | Sub-score |
|---|---|
| short interest | 9.9 |
| days to cover | 10.0 |
| volatility | 8.0 |
| put call | 10.0 |
| implied vol | 2.0 |
| max pain risk | 3.0 |
| beta | 9.3 |
| debt equity | 8.3 |
| Component | Sub-score |
|---|---|
| erm | 3.5 |
| earnings history | 1.1 |
| earnings timing | 5.0 |
| surprise avg | 0.0 |
| dividend safety | 5.3 |
Quality below minimum threshold.
L1:HARD_BLOCK:QUALITY_FLOORnone
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityModerate — Balanced profile
The SELL_IF_HOLDING verdict reflects the ASYMMETRY gate's -0.3=NEGATIVE outcome against Value at 9.4 and asymmetric R:R of -0.34.
The strongest dimensions are Value at 9.4, Risk (lower is worse) at 7.6, and Momentum at 6.5; the weakest are Growth at 2.0, Peer rank at 2.7, and Catalyst at 3.0. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of -0.34 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifForward P/E rises above 12x from current 8.7x.
Trip ifPrice exceeds 10% above the $8.39 analyst target, above about $9.23.
Trip ifQuality score falls below 3.0 from current 3.6.
Trip ifRevenue decline exceeds 15% YoY from current -8%.
Trip ifDividend is cut by more than 20% from the current rate.